Neonatal Erythropoietin in Asphyxiated Term Newborns
Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and pharmacokinetics of moderate to high
doses of erythropoietin in newborn infants with birth asphyxia.
Phase:
Phase 1
Details
Lead Sponsor:
University of California, San Francisco
Collaborators:
Children's Hospital & Research Center Oakland Santa Clara Valley Health & Hospital System Thrasher Research Fund UCSF Benioff Children's Hospital Oakland University of Washington